David R. Bauer
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/25898_drbauer.jpg?itok=Y1b0J_im)
Filters
Davis Polk Advises Comcast on Its Acquisition of Icontrol
Davis Polk is advising Comcast Corporation on its acquisition of Icontrol Networks, Inc. The transaction is expected to close by the end of 2016 and is subject to customary closing…
Spark Therapeutics Follow-On Offering
Davis Polk advised the representative of the underwriters in connection with the $181 million public offering of 4,025,000 shares of common stock of Spark Therapeutics, Inc. (“Spark”),…
Davis Polk Advises Mortgage Electronic Registration System Inc. (MERS) on Its Acquisition by ICE
Davis Polk is advising MERSCORP Holdings, Inc., owner of Mortgage Electronic Registrations Systems, Inc., on its acquisition by Intercontinental Exchange (ICE), the owner of the New York…
The Medicines Company $402.5 Million Convertible Senior Notes Offering
Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million aggregate principal amount of 2.75% convertible senior notes due…
SecureWorks Corp. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $112 million initial public offering by SecureWorks Corp. of 8,000,000 shares of…
Editas Medicine, Inc. $108.6 Million Initial Public Offering
Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $108.6 million initial public offering of 6,785,000 shares of common…
Mylan N.V. $1 Billion Notes Offering
Davis Polk advised the representatives of the initial purchasers on two Rule 144A/Regulation S offerings by Mylan N.V. of $500 million aggregate principal amount of its 3.000% senior notes…
Davis Polk Advises Fandango on Its Acquisition of Ingresso.com
Davis Polk is advising Fandango in connection with its acquisition of Ingresso.com from B2W Companhia Digital, a Latin American e-commerce company. The financial terms of the transaction…
Biogen Inc. $6 Billion Senior Notes Offering
Davis Polk advised the underwriters, in connection with the SEC-registered offering by Biogen Inc. of $1.5 billion principal amount of 2.900% senior notes due 2020, $1.0 billion principal…
Aimmune Therapeutics, Inc. $183.9 Million Initial Public Offering
Davis Polk advised the underwriters in connection with the $183.9 million initial public offering of Aimmune Technologies, Inc. Aimmune Therapeutics sold 11,499,999 shares of its…